NiSource accelerates clean-energy expansion with a 14.7% revenue growth outlook for 2025.

UAMY's rapid domestic antimony revival and TMC's long-cycle seabed strategy highlight two distinctly different approaches in critical minerals.

While you've been sweating the details over Thanksgiving, famed investor Michael Burry – the one portrayed by Christian Bale played in “The Big Short” – has been waging an increasingly aggressive war against Nvidia.

AFRM's BNPL-driven surge puts it ahead, while MA's global scale reach keeps it firmly in the race as flexible credit rapidly reshapes spending.

Automation and robotics continue to reshape the technology landscape, powering everything from autonomous delivery to advanced semiconductor testing. Two companies at very different stages of maturity—Serve Robotics Inc. SERV and Teradyne, Inc. TER—demonstrate how rapidly the robotics and AI ecosystem is evolving.

Artificial intelligence continues to reshape the defense landscape, and both emerging innovators and established integrators are competing aggressively for relevance across federal agencies. BigBear.ai Holdings, Inc. BBAI and Leidos Holdings, Inc. LDOS sit at two different ends of this spectrum.

MLTX Investors with Losses Encouraged to Contact the Firm San Francisco, California--(Newsfile Corp. - November 27, 2025) - MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company, has been hit with a securities fraud class action lawsuit after its share price plummeted nearly 90% in a single day. The sharp decline was triggered by the release of disappointing Phase 3 trial results for its lead and only drug candidate, sonelokimab (SLK).

NEW YORK , Nov. 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important December 29, 2025 lead plaintiff deadline. So what: If you purchased Avantor common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

With ALGT shares moving south, we assess the current positioning of the stock to determine if it's a good investment at this juncture.

Cipher Mining's mining momentum meets rising competition from Circle Internet Group as both chase growth in a crypto market expanding at a rapid pace.

BRBS refocuses on core banking after fintech exit, credit recoveries and income gains boost its turnaround momentum.

FIG's surging paid customer base and the rapid adoption of new AI tools spotlight strengthening growth momentum despite rising competition.

Strategy Executive chairman and founder Michael Saylor dissects what Bitcoin's pullback means for investors and explains why his business model is 'pretty indestructible' on 'Making Money.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #makingmoney #michaelsaylor #bitcoin #crypto #cryptocurrency #business #finance #economy #markets #investment #investors #technology #digitalcurrency #entrepreneur #innovation #strategy #wallstreet #money #stocks #trading #economicnews

KO's global scale and diverse portfolio meet COCO's rapid growth in the battle for better-for-you beverages. Both are shaping the future of natural hydration.

TSCO posts 7% Q3 sales growth and expands margins as strong rural demand and disciplined cost control offset tariff pressures.

The energy sector is witnessing a shift in how investors view Independent Power Producers (IPPs). Historically, companies that generated and sold electricity on the open market were seen as volatile, risky investments tied strictly to the ups and downs of commodity prices.

NKE faces a 10% revenue decline in China but leans on sport-led innovations and a global playbook to restore momentum across key markets.

Houlihan Lokey (HLI) possesses solid growth attributes, which could help it handily outperform the market.

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Neurocrine (NBIX) is well positioned to outperform the market, as it exhibits above-average growth in financials.